Myosteatosis as an independent predictor of short-term mortality in successfully reperfused acute ischemic stroke.
Matteo BonattiFabio LombardoRiccardo VallettaAlessio ComaiBenedetto PetraliaGiacomo AvesaniEnrica FranchiniAndrea RossiNicoletta De SantisMassimo GuerrieroFederica FerroPublished in: The neuroradiology journal (2022)
Beyond other well-known variables, low masseter attenuation, indicating myosteatosis, represents an independent negative prognostic factor for 90 days mortality in patients successfully reperfused after anterior circulation stroke.